(28) demonstrated that NLRP3 overexpression enhanced in vitro proliferation, migration, and invasion of endometrial cancer cells and increased active caspase-1 (cleaved caspase-1 p10), whereas in vivo knockdown of NLRP3 inhibited the growth of implanted endometrial cancer. The gene discussed is CASP1; the disease is endometrial cancer.